中文
|
English
Home
|
Help
|
Contact
Return
Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis?
10.5009/gnl210246
Author:
Sang Hyoung PARK
1
; Byong Duk YE ; Suk-Kyun YANG
Author Information
1. Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Publication Type:
Letter to the Editor
From:
Gut and Liver 2022;16(1):138-140
Country
Republic of Korea
Language:
English